Secondaries announced 8.17.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Eiger BioPharmaceuticals, Inc. Symbol: EIGR Price: Last trade $17.19 Description: Re-offer range $16.00-$16.50 Trade Date: 8/18 Shares: 1.16 million Underwriter(s) JefferiesCo[…]